Skip to main content
Clinical Trials/NCT00222742
NCT00222742
Terminated
Phase 3

Pediatric Traumatic Brain Injury Consortium: Hypothermia

Phoenix Children's Hospital30 sites in 6 countries90 target enrollmentNovember 2007

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Traumatic Brain Injury
Sponsor
Phoenix Children's Hospital
Enrollment
90
Locations
30
Primary Endpoint
The primary specific aim of this RCT is to determine the effect of induced moderate HYPO (32-33 °C) after severe TBI in children on mortality.
Status
Terminated
Last Updated
13 years ago

Overview

Brief Summary

The primary hypothesis for this application for a multicenter phase III randomized clinical trial (RCT) is that induced moderate hypothermia (HYPO) (32-33 °C) after severe traumatic brain injury (TBI) in children and maintained for 48 hours will improve mortality at 3 months and 12 month functional outcome as assessed by the Glasgow Outcome Scale (GOS).

Detailed Description

The primary specific aim of this RCT is to determine the effect of induced moderate HYPO (32-33 °C) after severe TBI in children on mortality at 3 months post injury. The primary outcome measure will be the GOS; the primary time point for evaluation is 3 months. Further secondary functional outcome measures will include the GOS - Extended Pediatrics (GOS - E Peds), and Vineland Adaptive Behavior Scale (VABS) and will be assessed in conjunction with the GOS at 6 and 12 months post injury. The secondary hypotheses are based on the results and analysis of the Pilot Clinical Trial (completed and recently published \[Adelson et al. NEUROSURGERY. 56 (4): 740-754, 2005\]). These secondary hypotheses include that induced moderate hypothermia (HYPO) (32-33 °C) after severe TBI in children and maintained for 48 h: * will improve other outcome assessments including neurocognitive status on performance-based neuropsychological testing across the domains of intellectual development, learning and memory, language, motor and psychomotor skills, visuo-spatial abilities, attention and executive function, and behavior at only 6 and 12 months after injury; * HYPO will improve long term outcome of all age ranges and across genders in infants, young, preadolescent, and adolescent children; AND * HYPO will lessen intracranial hypertension and lessen the intensity of therapy necessary for control of ICP. Based on these hypotheses, further secondary specific aims are proposed: * Specific Aim 2: To determine the effect of early induced moderate HYPO (32-33°C) after severe TBI in children on global function and neurocognitive outcomes in the areas of intellectual ability/ development, memory and learning, and behavior at 6 and 12 months post injury. * Specific Aim 3: To determine the effect of early induced moderate HYPO after severe TBI in children of different age ranges (\< 6 y and 6- \< 16 y) on mortality and 6 and 12 months functional and neurocognitive outcomes. * Specific Aim 4: To determine the effect of early moderate HYPO after severe TBI in children on reducing intracranial hypertension and maintaining adequate cerebral perfusion pressure (CPP).

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
March 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with a GCS \</= 8
  • Glasgow Motor Score \< 6
  • Closed head injury
  • Age 0 \< 18 y
  • Exclusion Criteria
  • Unavailable to initiate cooling within 6 hours of injury
  • Glasgow Coma Scale (GCS) score = 3 and abnormal brainstem function
  • Normal initial CT scan (No blood, fracture, swelling, and/or shift)
  • Penetrating brain injury
  • No known mechanism of injury

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The primary specific aim of this RCT is to determine the effect of induced moderate HYPO (32-33 °C) after severe TBI in children on mortality.

Time Frame: 3 month post injury

Secondary Outcomes

  • To determine the effect of HYPO after severe TBI in children on global function and neurocognitive outcomes in the areas of intellectual ability/development, memory and learning, and behavior.(at 6 and 12 months post injury)
  • To determine the effect of HYPO after severe TBI in children of different age ranges (< 6y; 6-<16y; and 16-<18y) on mortality and 6 and 12 months functional and neurocognitive outcomes.(3, 6 and 12 months post injury)
  • To determine the effect of HYPO after severe TBI in children on reducing intracranial hypertension and maintaining adequate cerebral perfusion pressure (CPP).(7 days post injury)

Study Sites (30)

Loading locations...

Similar Trials